Agilent Technologies, Inc. $A Shares Sold by Qsemble Capital Management LP

Qsemble Capital Management LP lowered its holdings in Agilent Technologies, Inc. (NYSE:A) by 77.4% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 23,610 shares of the medical research company’s stock after selling 80,925 shares during the quarter. Qsemble Capital Management LP’s holdings in Agilent Technologies were worth $3,136,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Fiduciary Trust Co boosted its holdings in Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after purchasing an additional 77 shares in the last quarter. Sapient Capital LLC increased its stake in Agilent Technologies by 4.2% in the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after purchasing an additional 85 shares during the last quarter. Plan A Wealth LLC raised its holdings in Agilent Technologies by 3.2% during the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after purchasing an additional 92 shares in the last quarter. IHT Wealth Management LLC raised its holdings in Agilent Technologies by 4.9% during the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock worth $278,000 after purchasing an additional 96 shares in the last quarter. Finally, KPP Advisory Services LLC lifted its position in shares of Agilent Technologies by 2.4% during the 2nd quarter. KPP Advisory Services LLC now owns 4,382 shares of the medical research company’s stock worth $582,000 after buying an additional 103 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on A shares. Barclays upped their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Robert W. Baird boosted their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Piper Sandler started coverage on Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Finally, TD Cowen lifted their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Price Performance

A stock opened at $148.55 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $41.96 billion, a P/E ratio of 29.83, a PEG ratio of 2.64 and a beta of 1.25. The business has a 50 day simple moving average of $135.38 and a 200-day simple moving average of $125.56. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the previous year, the company posted $1.31 EPS. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities analysts anticipate that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is currently 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.